Bioxcel TherapeuticsBTAIQ

13F holders, Q4 2025 (December 31)
41holders +6
11new positions
4sold out
2famous investors
$1.60avg. 13F price*

At the end of Q4 2025, 41 institutions reported holding Bioxcel Therapeutics Inc. (BTAIQ) in their 13F filings, up 6 from Q3 2025. 11 opened new positions and 4 sold out. The largest holders were Millennium Management ($2.9M), Vanguard Group Inc. ($468K) and Oaktree Capital Management ($386K). 2 famous investors held it, including Howard Marks (0.0% of Oaktree Capital Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Bioxcel Therapeutics Inc.
CUSIP
09075P204
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2025: 31Q1 2025Q2 2025: 35Q2 2025Q3 2025: 35Q3 2025Q4 2025: 41Q4 2025Q1 2026: 40Q1 2026Q2 2026: 47Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions11$584K
Exits4$451K

All 13F filers, Q3 2025 → Q4 2025: 1,486,781 shares bought and 307,579 shares sold, net +1,179,202 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 41 holders

Millennium Management 0.00% Add +78.5% 1,835,192 $2.9M
Vanguard Group Inc. 0.00% Add +52.4% 292,753 $468K
Oaktree Capital Management 0.01% No change 241,188 $386K
Geode Capital Management, LLC 0.00% Add +64.6% 206,168 $330K
Jones Financial Companies LLLP 0.00% Add +282.5% 137,690 $220K
Jane Street Group, LLC 0.00% New 127,501 $204K
Gsa Capital Partners LLP 0.02% New 120,102 $192K
FMR LLC 0.00% Reduce -54.5% 90,300 $144K
BlackRock, Inc. 0.00% Add +0.1% 84,396 $135K
State Street Corp. 0.00% Add +19.9% 63,218 $101K
Man Group plc 0.00% New 56,825 $91K
Oaktree Fund Advisors, LLC 0.13% No change 42,913 $69K
HighTower Advisors, LLC 0.00% Add +17.1% 41,000 $66K
Northern Trust Corp. 0.00% Add +1.7% 38,370 $61K
UBS Group AG 0.00% Reduce -11.9% 38,340 $61K
Diversify Wealth Management, LLC 0.00% No change 15,000 $31K
HRT Financial LP 0.00% New 18,062 $28K
Two Sigma Securities, LLC 0.00% New 17,068 $27K
Osaic Holdings, Inc. 0.00% Add +4.4% 15,749 $25K
Engineers Gate Manager LP 0.00% New 12,303 $20K
Portfolio Strategies, Inc. 0.00% New 12,178 $19K
Citigroup Inc. 0.00% Add +3302.5% 12,079 $19K
IFP Advisors, Inc 0.00% No change 4,370 $7K
Wells Fargo & Company 0.00% Reduce -73.5% 4,325 $7K
Group One Trading LLC 0.00% Add +41.6% 3,185 $5K
Caitong International Asset Management Co., Ltd 0.00% New 1,642 $3K
Morgan Stanley 0.00% Reduce -10.8% 1,464 $2K
Bank of America Corp. 0.00% Reduce -79.0% 1,446 $2K
NewEdge Advisors, LLC 0.00% No change 1,331 $2K
SBI Securities Co., Ltd. 0.00% No change 169 $270
Washington Trust Advisors, Inc. 0.00% No change 160 $256
Parkside Financial Bank & Trust 0.00% No change 112 $180
Annis Gardner Whiting Capital Advisors, LLC 0.00% New 112 $180
EverSource Wealth Advisors, LLC 0.00% No change 60 $96
JPMorgan Chase & Co. 0.00% No change 45 $72
Farther Finance Advisors, LLC 0.00% New 25 $40
Northwestern Mutual Wealth Management Co. 0.00% No change 21 $34
BNP Paribas Financial Markets 0.00% Reduce -69.2% 12 $19
Zurcher Kantonalbank (Zurich Cantonalbank) 0.00% Reduce -98.1% 2 $3
US Bancorp \de 0.00% No change 1 $2
Triumph Capital Management 0.00% New 1 $2

"% of holder's portfolio" is BTAIQ's weight in each manager's 13F, not the share of Bioxcel Therapeutics Inc. the manager owns.